Kyle Diamantas
American attorney (born 1987)
From Wikipedia, the free encyclopedia
Kyle Allen Diamantas (born November 25, 1987) is an American attorney who has served as the acting commissioner of food and drugs since May 2026, following Marty Makary's resignation. He is also the acting deputy commissioner for human foods, since February 2025.
_(cropped).jpg)
Kyle Diamantas | |
|---|---|
Official portrait, 2025 | |
| Acting Commissioner of Food and Drugs | |
| Assumed office May 12, 2026 | |
| President | Donald Trump |
| Preceded by | Marty Makary |
| Acting Deputy Commissioner for Human Foods | |
| Assumed office February 24, 2025 | |
| President | Donald Trump |
| Commissioner | Marty Makary |
| Preceded by | Jim Jones |
| Personal details | |
| Born | Kyle Allen Diamantas November 25, 1987 Rockledge, Florida, U.S. |
| Education | |
Diamantas graduated from the University of Central Florida with a degree in political science in 2010 and from the University of Florida with a Juris Doctor in 2013. In 2024, Diamantas became a partner at Jones Day.
Early life and education (1987–2013)
Kyle Allen Diamantas was born on November 25, 1987, in Rockledge, Florida.[1] Diamantas attended Merritt Island High School, where he played baseball.[2] He graduated from the University of Central Florida with a degree in pre-law political science in 2010 and from the University of Florida with a Juris Doctor in 2013.[3] Diamantas is a hunter and has been photographed hunting with Donald Trump Jr.[4]
Career
Legal work (2012–2024)
From 2012 to 2021, Diamantas worked for Baker Donelson. At that firm, he represented Hemp Bombs in a lawsuit against its cannabidiol products and defended Whole Foods Market in a claim that it sold a cannabidiol product under false pretenses.[5]
In July 2021, Diamantas was named as a counsel for Jones Day;[6] in 2024, he became a partner at the firm.[4] In March 2024, Diamantas began representing Abbott Laboratories in a lawsuit that claimed the company knowingly sold harmful infant formula. In July 2024, Abbott lost the lawsuit; the jury awarded the plantiff $495 million.[7]
Diamantas also represented British American Tobacco.[5]
Food and Drug Administration (2024–present)
In November 2024, Diamantas was a member of a post-market safety assessment group established by the Food and Drug Administration to review chemicals in food. By February 2025, he had become a special assistant in the office of the commissioner of food and drugs. That month, Bloomberg News reported that Diamantas had been appointed to succeed Jim Jones as the acting deputy commissioner for human foods.[8] He was publicly listed on the Food and Drug Administration's website on February 24.[5]
As the deputy commissioner for human foods, Diamantas was in charge of the agency's process for creating the definition of ultra-processed food. He told The New York Times that the Food and Drug Administration would consider the use of synthetic dyes, emulsifiers, and preservatives in creating that definition.[9]
Diamantas was additionally responsible for reviewing infant formula, an authority that caused a possible conflict of interest; the agency told the Times that he had agreed to recuse himself from matters involving Abbott Laboratories and British American Tobacco.[5] Diamantas sought to fulfill the priorities of Secretary of Health and Human Services Robert F. Kennedy Jr. and the Make America Healthy Again movement.[10]
In February 2026, The Wall Street Journal reported that Diamantas had been appointed to assist Chris Klomp in managing the Food and Drug Administration at the Department of Health and Human Services.[11]
On May 12, 2026, Marty Makary, the commissioner of food and drugs, resigned from his position over his refusal to authorize flavored vapes. Diamantas was named as the acting commissioner.[12]